Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [A multicentric, randomized, double-blind, placebo-controlled Phase III study of ARN-509 in men with non-metastatic (M0) castration-resistant prostate cancer (SPARTAN): AUO study AP 82/14].

Literature DB >> 26820656

[A multicentric, randomized, double-blind, placebo-controlled Phase III study of ARN-509 in men with non-metastatic (M0) castration-resistant prostate cancer (SPARTAN): AUO study AP 82/14].

H Rexer¹, P Hammerer².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2016 PMID： 26820656 DOI： 10.1007/s00120-016-0032-6

Source DB: PubMed Journal: Urologe A ISSN： 0340-2592 Impact factor: 0.639

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

Review 1. Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer.

Authors: Zaina T Al-Salama
Journal: Drugs Date: 2019-09 Impact factor: 9.546

2. The impact of time to metastasis on overall survival in patients with prostate cancer.

Authors: Sebastian Frees; Shusuke Akamatsu; Samir Bidnur; Daniel Khalaf; Claudia Chavez-Munoz; Werner Struss; Bernhard J Eigl; Martin Gleave; Kim N Chi; Alan So
Journal: World J Urol Date: 2018-02-27 Impact factor: 4.226

Review 3. ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer.

Authors: Karim Fizazi; Laurence Albiges; Yohann Loriot; Christophe Massard
Journal: Expert Rev Anticancer Ther Date: 2015 Impact factor: 4.512

3 in total